Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Imv Inc (NQ: IMV ) N/A UNCHANGED Last Price Updated: 3:58 PM EDT, Apr 28, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Imv Inc < Previous 1 2 3 Next > IMV Inc. Presents Clinical Benefit of MVP-S in Combination with Pembrolizumab in Bladder Cancer at the AACR Annual Meeting April 08, 2022 From IMV Inc. Via Business Wire IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting April 06, 2022 From IMV Inc. Via Business Wire IMV Inc. to Present at Two Upcoming Investor Conferences April 04, 2022 From IMV Inc. Via Business Wire IMV Inc. Announces Fourth Quarter and Full Year 2021 Financial and Operational Results March 17, 2022 From IMV Inc. Via Business Wire IMV to Host a Webcast to Highlight its Immune-Educating DPX® Platform February 17, 2022 From IMV Inc. Via Business Wire IMV Announces First Patient Dosed in the VITALIZE Phase 2B Clinical Study Evaluating its Lead Compound, MVP-S, in Combination with KEYTRUDA® (pembrolizumab) in Patients with r/r DLBCL January 12, 2022 From IMV Inc. Via Business Wire IMV Inc. to Present at Two Upcoming Investor Events January 05, 2022 From IMV Inc. Via Business Wire IMV Appoints Andrew Hall as Chief Executive Officer December 22, 2021 From IMV Inc. Via Business Wire IMV Announces Finalization of the Basket Clinical Study in Collaboration with Merck and Reveals Promising Top Line Data from the Bladder and MSI-High Cohorts December 21, 2021 From IMV Inc. Via Business Wire IMV Strengthens its Financial Position with the Completion of a US$25 Million Long-Term Debt Facility December 20, 2021 From IMV Inc. Via Business Wire Role of B Cells Induced by IMV’s Lead Compound in Patients with Ovarian Cancer to be Showcased at the ESMO-IO Congress December 02, 2021 From IMV Inc. Via Business Wire IMV Announces First Patient Dosed in Phase 1b Clinical Study Evaluating its Lead Compound in Patients with Breast Cancer November 30, 2021 From IMV Inc. Via Business Wire IMV Inc. to Present at the Piper Sandler Virtual Healthcare Conference November 23, 2021 From IMV Inc. Via Business Wire IMV Inc. Announces Chief Financial Officer to Retire November 22, 2021 From IMV Inc. Via Business Wire IMV Inc. Announces Third Quarter 2021 Financial and Operational Update November 10, 2021 From IMV Inc. Via Business Wire Translational Data From the DeCidE1 Clinical Study in Patients with Advanced, Recurrent Ovarian Cancer to be Presented at SITC Annual Meeting November 09, 2021 From IMV Inc. Via Business Wire IMV Inc. to Announce Third Quarter 2021 Results and Host a Conference Call and Webcast on November 11, 2021 November 04, 2021 From IMV Inc. Via Business Wire Immunotherapeutic Benefits of the DPX Delivery Platform Featured in Two Poster Presentations at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics October 07, 2021 From IMV Inc. Via Business Wire Potential Response Predictors to IMV’s Lead Compound in the DeCidE Clinical Study in Patients with Advanced, Recurrent Ovarian Cancer to be Presented at SITC Annual Meeting October 01, 2021 From IMV Inc. Via Business Wire IMV’s DPX Delivery Technology to be Showcased in Two e-Posters at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics September 30, 2021 From IMV Inc. Via Business Wire IMV Inc. to Present at Three Investor Conferences in September September 01, 2021 From IMV Inc. Via Business Wire IMV Inc. Announces Second Quarter 2021 Financial and Operational Results August 11, 2021 From IMV Inc. Via Business Wire IMV Announces Final Topline Results of the DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer August 10, 2021 From IMV Inc. Via Business Wire IMV Announces CEO Transition August 04, 2021 From IMV Inc. Via Business Wire IMV Inc. to Announce Second Quarter 2021 Results and Host a Conference Call and Webcast on August 11, 2021 August 02, 2021 From IMV Inc. Via Business Wire IMV to Participate in the BTIG Virtual Biotechnology Conference July 29, 2021 From IMV Inc. Via Business Wire IMV Inc. Closes Previously Announced Public Offering July 20, 2021 From IMV Inc. Via Business Wire IMV Inc. Announces Pricing of Public Offering July 15, 2021 From IMV Inc. Via Business Wire IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Units July 14, 2021 From IMV Inc. Via Business Wire IMV Announces Annual and Special Meeting of Shareholders Voting Results June 18, 2021 From IMV Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.